Table 3 Cure Rates by Monomicrobial/Polymicrobial Infection at the Test-of-Cure Visit
From: Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
| Â | Tigecycline | Levofloxacin | Difference (Tigecycline -- Levofloxacin) | ||
|---|---|---|---|---|---|
| Â | n/N | % (95% CI) | n/N | % (95% CI) | % (95% CI) |
ME | Â | Â | Â | Â | Â |
   Monomicrobial | 53/58 | 91.4 (81.0, 97.1) | 56/64 | 87.5 (76.8, 94.4) | 3.9 (-9.0, 16.3) |
   Polymicrobial | 25/28 | 89.3 (71.8, 97.7) | 20/21 | 95.2 (76.2, 99.9) | -6.0 (-25.1, 16.6) |
m-mITT | Â | Â | Â | Â | Â |
   Monomicrobial | 74/84 | 88.1 (79.2, 94.1) | 76/88 | 86.4 (77.4, 92.8) | 1.7 (-9.4, 12.7) |
   Polymicrobial | 28/34 | 82.4 (65.5, 93.2) | 23/25 | 92.0 (74.0, 99.0) | -9.6 (-28.4, 12.4) |